Title: Bifeprunox: a partial agonist at dopamine D2 and serotonin 1A receptors, influences nicotine-seeking behaviour in response to drug-associated stimuli in rats.
Journal: Addiction biology 20120301
Title: Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.
Journal: Journal of medicinal chemistry 20110714
Title: Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
Journal: Behavioural brain research 20091105
Title: Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
Journal: Neuroscience letters 20090821
Title: Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour.
Journal: Journal of psychopharmacology (Oxford, England) 20090301
Title: Dopamine D2(High) receptors moderately elevated by bifeprunox and aripiprazole.
Journal: Synapse (New York, N.Y.) 20081201
Title: Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study.
Journal: Psychopharmacology 20081001
Title: The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
Journal: European journal of pharmacology 20080911
Title: Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912.
Journal: European journal of pharmacology 20071128
Title: Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation.
Journal: Journal of neurochemistry 20070801
Title: Neuropharmacological profile of bifeprunox: merits and limitations in comparison with other third-generation antipsychotics.
Journal: Current opinion in investigational drugs (London, England : 2000) 20070701
Title: Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
Journal: Psychopharmacology 20070401
Title: Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Journal: European journal of pharmacology 20060327
Title: Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
Journal: The Journal of pharmacology and experimental therapeutics 20051001
Title: Molecule of the month. Bifeprunox mesilate.
Journal: Drug news & perspectives 20051001
Title: Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
Journal: Neuropharmacology 20050801
Title: DU-127090 Solvay/H Lundbeck.
Journal: Current opinion in investigational drugs (London, England : 2000) 20030101
